CME Group Inc. (CME)

FORM 10-Q | Quarterly Report
Aug. 7, 2019 2:54 PM
|
About: CME Group Inc. (CME)View as PDF
CME GROUP INC. (Form: 10-Q, Received: 08/07/2019 14:55:06)
false--12-31Q220190001156375761100000843600000270000028000000.701.400.751.500.010.010.010.01100000000030001000000000300035682400030003571430003000356824000300035714300030001500000015000000191000000005000000005000000007000000007000000007500000007500000007500000007500000007500000007500000000.04300.00810.03130.03750.04150.03000.03000.05302023-05-012023-05-312019-03-312019-03-312028-06-152028-06-152048-06-152048-06-152025-03-152025-03-152022-09-152022-09-152043-09-152043-09-150.010.011000000010000000000015000001200000 0001156375 2019-01-01 2019-06-30 0001156375 cme:ClassBCommonStockClassB3Member 2019-07-10 0001156375 us-gaap:CommonClassAMember 2019-07-10 0001156375 cme:ClassBCommonStockClassB1Member 2019-07-10 0001156375 cme:ClassBCommonStockClassB4Member 2019-07-10 0001156375 cme:ClassBCommonStockClassB2Member 2019-07-10 0001156375 us-gaap:CommonClassBMember 2019-06-30 0001156375 2019-06-30 0001156375 2018-12-31 0001156375 us-gaap:CommonClassAMember 2019-06-30 0001156375 us-gaap:CommonClassAMember 2018-12-31 0001156375 us-gaap:CommonClassBMember 2018-12-31 0001156375 us-gaap:PreferredStockMember 2019-06-30 0001156375 us-gaap:PreferredStockMember 2018-12-31 0001156375 2019-04-01 2019-06-30 0001156375 2018-01-01 2018-06-30 0001156375 2018-04-01 2018-06-30 0001156375 cme:OtherRevenueMember 2019-04-01 2019-06-30 0001156375 cme:MarketDataMember 2018-04-01 2018-06-30 0001156375 cme:MarketDataMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember 2018-04-01 2018-06-30 0001156375 cme:OtherRevenueMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember 2019-01-01 2019-06-30 0001156375 cme:MarketDataMember 2019-04-01 2019-06-30 0001156375 cme:OtherRevenueMember 2019-01-01 2019-06-30 0001156375 cme:OtherRevenueMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember 2018-01-01 2018-06-30 0001156375 cme:MarketDataMember 2018-01-01 2018-06-30 0001156375 us-gaap:CommonClassBMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2017-12-31 0001156375 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001156375 2018-06-30 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001156375 us-gaap:CommonClassBMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-06-30 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2017-12-31 0001156375 us-gaap:RetainedEarningsMember 2017-12-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2017-12-31 0001156375 us-gaap:RetainedEarningsMember 2018-06-30 0001156375 2017-12-31 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-06-30 0001156375 us-gaap:CommonClassBMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-03-31 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-03-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001156375 us-gaap:RetainedEarningsMember 2018-03-31 0001156375 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001156375 2018-03-31 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-03-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001156375 us-gaap:CommonClassBMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-06-30 0001156375 us-gaap:CommonClassBMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0001156375 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001156375 us-gaap:NoncontrollingInterestMember 2019-03-31 0001156375 us-gaap:ParentMember 2019-04-01 2019-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-06-30 0001156375 us-gaap:NoncontrollingInterestMember 2019-06-30 0001156375 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0001156375 us-gaap:RetainedEarningsMember 2019-03-31 0001156375 us-gaap:ParentMember 2019-06-30 0001156375 us-gaap:ParentMember 2019-03-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001156375 us-gaap:RetainedEarningsMember 2019-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-06-30 0001156375 2019-03-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001156375 us-gaap:ParentMember 2019-01-01 2019-06-30 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001156375 us-gaap:RetainedEarningsMember 2018-12-31 0001156375 us-gaap:CommonClassAMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001156375 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001156375 us-gaap:CommonClassBMember us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001156375 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001156375 us-gaap:ParentMember 2018-12-31 0001156375 us-gaap:NoncontrollingInterestMember 2018-12-31 0001156375 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001156375 2019-01-01 0001156375 cme:ClearingandtransactionfeesMember cme:MetalMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:MetalMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:MetalMember 2018-04-01 2018-06-30 0001156375 us-gaap:TransferredAtPointInTimeMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:InterestRateMember 2019-01-01 2019-06-30 0001156375 us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:CashMarketsMember 2019-04-01 2019-06-30 0001156375 us-gaap:TransferredOverTimeMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:AgriculturalcommodityMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EquitiesMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:MetalMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:CashMarketsMember 2018-01-01 2018-06-30 0001156375 cme:OnetimechargesandmiscellaneousrevenuesMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:ForeignExchangeMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EquitiesMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:OverTheCounterMember 2018-04-01 2018-06-30 0001156375 cme:OnetimechargesandmiscellaneousrevenuesMember 2018-04-01 2018-06-30 0001156375 cme:OnetimechargesandmiscellaneousrevenuesMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:InterestRateMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EnergyMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EnergyMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:CashMarketsMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:AgriculturalcommodityMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:AgriculturalcommodityMember 2018-01-01 2018-06-30 0001156375 us-gaap:TransferredOverTimeMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EnergyMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:ForeignExchangeMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:OverTheCounterMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:OverTheCounterMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:InterestRateMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:InterestRateMember 2018-01-01 2018-06-30 0001156375 us-gaap:TransferredAtPointInTimeMember 2019-04-01 2019-06-30 0001156375 cme:OnetimechargesandmiscellaneousrevenuesMember 2019-04-01 2019-06-30 0001156375 us-gaap:TransferredOverTimeMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:CashMarketsMember 2018-04-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:ForeignExchangeMember 2018-04-01 2018-06-30 0001156375 us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EquitiesMember 2019-01-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EnergyMember 2018-01-01 2018-06-30 0001156375 us-gaap:TransferredOverTimeMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:ForeignExchangeMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:EquitiesMember 2018-01-01 2018-06-30 0001156375 cme:ClearingandtransactionfeesMember cme:AgriculturalcommodityMember 2019-04-01 2019-06-30 0001156375 cme:ClearingandtransactionfeesMember us-gaap:OverTheCounterMember 2019-01-01 2019-06-30 0001156375 cme:FederalReserveReinvestmentMember 2019-06-30 0001156375 us-gaap:ConsolidatedEntitiesMember 2017-12-31 0001156375 cme:NymexMember 2018-12-31 0001156375 us-gaap:GoodwillMember 2018-12-31 0001156375 us-gaap:GoodwillMember 2019-06-30 0001156375 us-gaap:ConsolidatedEntitiesMember 2019-01-01 2019-06-30 0001156375 us-gaap:GoodwillMember 2019-01-01 2019-06-30 0001156375 us-gaap:ConsolidatedEntitiesMember 2019-06-30 0001156375 cme:NEXMember 2019-01-01 2019-06-30 0001156375 us-gaap:ConsolidatedEntitiesMember 2018-01-01 2018-12-31 0001156375 cme:NymexMember 2019-01-01 2019-06-30 0001156375 cme:NEXMember 2018-01-01 2018-12-31 0001156375 us-gaap:ConsolidatedEntitiesMember 2018-12-31 0001156375 cme:CBOTMember 2019-01-01 2019-06-30 0001156375 cme:NymexMember 2019-06-30 0001156375 cme:NymexMember 2018-01-01 2018-12-31 0001156375 cme:CBOTMember 2017-12-31 0001156375 cme:NEXMember 2017-12-31 0001156375 cme:CBOTMember 2019-06-30 0001156375 cme:NEXMember 2019-06-30 0001156375 cme:CBOTMember 2018-01-01 2018-12-31 0001156375 cme:NEXMember 2018-12-31 0001156375 cme:CBOTMember 2018-12-31 0001156375 cme:NymexMember 2017-12-31 0001156375 us-gaap:GoodwillMember 2018-01-01 2018-12-31 0001156375 us-gaap:GoodwillMember 2017-12-31 0001156375 us-gaap:CustomerRelationshipsMember 2019-06-30 0001156375 us-gaap:OtherIntangibleAssetsMember 2018-12-31 0001156375 us-gaap:TradeNamesMember 2019-06-30 0001156375 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001156375 us-gaap:FiniteLivedIntangibleAssetsMember 2018-12-31 0001156375 us-gaap:FiniteLivedIntangibleAssetsMember 2019-06-30 0001156375 us-gaap:TradeNamesMember 2018-12-31 0001156375 us-gaap:DevelopedTechnologyRightsMember 2019-06-30 0001156375 us-gaap:CustomerRelationshipsMember 2018-12-31 0001156375 us-gaap:OtherIntangibleAssetsMember 2019-06-30 0001156375 us-gaap:CommercialPaperMember 2018-12-31 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2022InterestEqualTo3.00Member 2018-12-31 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member 2018-12-31 0001156375 cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75MemberDomain 2018-12-31 0001156375 cme:A15.0millionfixedratenotesdueMay2023Member 2019-06-30 0001156375 cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75MemberDomain 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member 2019-06-30 0001156375 cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member 2019-06-30 0001156375 us-gaap:CommercialPaperMember 2019-06-30 0001156375 cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member 2018-12-31 0001156375 cme:A15.0millionfixedratenotesdueMay2023Member 2018-12-31 0001156375 cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain 2018-12-31 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2022InterestEqualTo3.00Member 2019-06-30 0001156375 cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain 2019-06-30 0001156375 2012-09-01 2012-09-30 0001156375 cme:A350.0millionfixedratenotesdueMarch2019Member 2019-06-30 0001156375 2015-03-01 2015-03-31 0001156375 2013-09-01 2013-09-30 0001156375 srt:MaximumMember 2019-04-01 2019-06-30 0001156375 cme:A19.1billiontermloandueMarch2019Member 2019-06-30 0001156375 us-gaap:CommercialPaperMember 2019-01-01 2019-06-30 0001156375 srt:MinimumMember 2019-04-01 2019-06-30 0001156375 cme:A350.0millionfixedratenotesdueMarch2019Member 2018-12-31 0001156375 cme:A19.1billiontermloandueMarch2019Member 2018-12-31 0001156375 cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75MemberDomain 2019-01-01 2019-06-30 0001156375 cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain 2019-01-01 2019-06-30 0001156375 cme:A15.0millionfixedratenotesdueMay2023Member 2019-01-01 2019-06-30 0001156375 cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member 2019-01-01 2019-06-30 0001156375 cme:A19.1billiontermloandueMarch2019Member 2019-01-01 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member 2019-01-01 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2022InterestEqualTo3.00Member 2019-01-01 2019-06-30 0001156375 cme:A350.0millionfixedratenotesdueMarch2019Member 2019-01-01 2019-06-30 0001156375 us-gaap:PropertySubjectToOperatingLeaseMember 2019-01-01 2019-06-30 0001156375 cme:PropertySubjecttoFinanceLeaseMember 2019-01-01 2019-06-30 0001156375 cme:FamilyFarmerAndRanchersProtectionFundMember 2019-06-30 0001156375 cme:FamilyFarmerAndRanchersProtectionFundMember 2019-01-01 2019-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001156375 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-06-30 0001156375 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-06-30 0001156375 us-gaap:ForeignCurrencyGainLossMember 2018-12-31 0001156375 us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-06-30 0001156375 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-06-30 0001156375 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001156375 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001156375 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001156375 us-gaap:ForeignCurrencyGainLossMember 2019-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001156375 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001156375 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001156375 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-06-30 0001156375 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-06-30 0001156375 us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-06-30 0001156375 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001156375 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-06-30 0001156375 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001156375 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001156375 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-06-30 0001156375 us-gaap:ForeignCurrencyGainLossMember 2018-06-30 0001156375 us-gaap:ForeignCurrencyGainLossMember 2017-12-31 0001156375 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001156375 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 0001156375 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 0001156375 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001156375 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2019-06-30 0001156375 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001156375 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001156375 us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-06-30 0001156375 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member us-gaap:FairValueInputsLevel2Member 2019-06-30 0001156375 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel3Member 2019-06-30 0001156375 cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain us-gaap:FairValueInputsLevel2Member 2019-06-30 0001156375 cme:A15.0millionfixedratenotesdueMay2023Member us-gaap:FairValueInputsLevel2Member 2019-06-30 0001156375 cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75MemberDomain us-gaap:FairValueInputsLevel2Member 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2022InterestEqualTo3.00Member us-gaap:FairValueInputsLevel2Member 2019-06-30 0001156375 cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member us-gaap:FairValueInputsLevel2Member 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2022InterestEqualTo3.00Member us-gaap:FairValueInputsLevel2Member 2019-01-01 2019-06-30 0001156375 cme:A700.0MillionFixedRateNotesDueJune2048InterestEqualTo4.15MemberDomainDomain us-gaap:FairValueInputsLevel2Member 2019-01-01 2019-06-30 0001156375 cme:A750.0millionFixedRateNotesDueSeptember2043InterestEqualTo5.3Member us-gaap:FairValueInputsLevel2Member 2019-01-01 2019-06-30 0001156375 cme:A750.0MillionFixedRateNotesDueMarch2025InterestEqualTo3.00Member us-gaap:FairValueInputsLevel2Member 2019-01-01 2019-06-30 0001156375 cme:A15.0millionfixedratenotesdueMay2023Member us-gaap:FairValueInputsLevel2Member 2019-01-01 2019-06-30 0001156375 cme:A500.0MillionFixedRateNotesDueJune2028InterestEqualTo3.75MemberDomain us-gaap:FairValueInputsLevel2Member 2019-01-01 2019-06-30 0001156375 us-gaap:RestrictedStockMember 2018-01-01 2018-06-30 0001156375 us-gaap:RestrictedStockMember 2018-04-01 2018-06-30 0001156375 us-gaap:RestrictedStockMember 2019-04-01 2019-06-30 0001156375 us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:JPY iso4217:USD xbrli:shares cme:years

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________
FORM 10-Q
_________________________________________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2019
- OR -
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                to                
Commission file number 001-31553
CME GROUP INC.
(Exact name of registrant as specified in its charter)
Delaware
 
 
 
36-4459170
(State or other jurisdiction of
incorporation or organization)
 
 
 
(I.R.S. Employer
Identification No.)
 
 
 
 
20 South Wacker Drive
Chicago
Illinois
 
60606
(Address of principal executive offices)
 
(Zip Code)
( 312 ) 930-1000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)  
Securities registered pursuant to Section 12(b) of the Act:
    
Title of each class
Trading symbol
Name of each exchange on which registered
Class A Common Stock
CME
Nasdaq
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.             Yes        No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                    Yes        No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
Accelerated filer
Non-accelerated filer  
 
Smaller reporting company
 
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    
Yes        No  
The number of shares outstanding of each of the registrant’s classes of common stock as of July 10, 2019 was as follows: 358,092,467 shares of Class A common stock, $0.01 par value; 625 shares of Class B-1 common stock, $0.01 par value; 813 shares of Class B-2 common stock, $0.01 par value; 1,287 shares of Class B-3 common stock, $0.01 par value; and 413 shares of Class B-4 common stock, $0.01 par value.

1




  CME GROUP INC.
FORM 10-Q
INDEX
 
 
 
 
 
Page
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 6.
 
 

2


PART I. FINANCIAL INFORMATION
Certain Terms
All references to “options” or “options contracts” in the text of this document refer to options on futures contracts.
Further information about CME Group and its products can be found at http://www.cmegroup.com. Information made available on our website does not constitute a part of this Quarterly Report on Form 10-Q.
Information about Contract Volume and Average Rate per Contract
All amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures contracts unless otherwise noted.
Trademark Information
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. NEX, BrokerTec, EBS, TriOptima, and Traiana are trademarks of various entities that are under NEX, all of which are owned by CME Group. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners.
Forward-Looking Statements
From time to time, in this Quarterly Report on Form 10-Q as well as in other written reports and verbal statements, we discuss our expectations regarding future performance. These forward-looking statements are identified by their use of terms and phrases such as “believe,” “anticipate,” “could,” “estimate,” “intend,” “may,” “plan,” “expect” and similar expressions, including references to assumptions. These forward-looking statements are based on currently available competitive, financial and economic data, current expectations, estimates, forecasts and projections about the industries in which we operate and management's beliefs and assumptions. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are:
increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities;
our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks;
our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide effective services to the swaps market;
our ability to adjust our fixed costs and expenses if our revenues decline;
our ability to maintain existing customers, develop strategic relationships and attract new customers;
our ability to expand and globally offer our products and services;
changes in regulations, including the impact of any changes in laws or government policy with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers;
the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others;
decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions;
changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure;

3


the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business;
the ability of our compliance and risk management methods to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets;
volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange rates;
economic, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers;
our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems;
our ability to execute our growth strategy and maintain our growth effectively;
our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the acquisition of NEX;
our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business;
industry and customer consolidation;
decreases in trading and clearing activity;
the imposition of a transaction tax or user fee on futures and options on futures transactions and/or repeal of the 60/40 tax treatment of such transactions;
our ability to maintain our reputation; and
the unfavorable resolution of material legal proceedings.
For a detailed discussion of these and other factors that might affect our performance, see Item 1A. of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 28, 2019 and Item 1A. of this Quarterly Report on Form 10-Q.

4


ITEM 1.
FINANCIAL STATEMENTS
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(dollars in millions, except par value data; shares in thousands)
 
 
June 30, 2019
 
December 31, 2018
 
 
(unaudited)
 
 
Assets
 
 
 
 
Current Assets:
 
 
 
 
Cash and cash equivalents
 
$
937.7

 
$
1,374.5

Marketable securities
 
81.8

 
72.9

Accounts receivable, net of allowance of $2.8 and $2.7
 
593.7

 
553.3

Other current assets (includes $4.1 and $1.5 in restricted cash)
 
359.7

 
430.5

Performance bonds and guaranty fund contributions
 
32,489.5

 
39,455.5

Total current assets
 
34,462.4

 
41,886.7

Property, net of accumulated depreciation and amortization of $843.6 and $761.1
 
500.4

 
448.7

Intangible assets—trading products
 
17,175.3

 
17,175.3

Intangible assets—other, net
 
5,308.7

 
5,500.1

Goodwill
 
10,795.3

 
10,805.3

Other assets (includes $1.1 and $1.2 in restricted cash)
 
2,107.4

 
1,659.6

Total Assets
 
$
70,349.5

 
$
77,475.7

 
 
 
 
 
Liabilities and Equity
 
 
 
 
Current Liabilities:
 
 
 
 
Accounts payable
 
$
51.6

 
$
116.0

Short-term debt
 

 
574.2

Other current liabilities
 
393.6

 
1,126.9

Performance bonds and guaranty fund contributions
 
32,489.5

 
39,455.5

Total current liabilities
 
32,934.7

 
41,272.6

Long-term debt
 
4,072.9

 
3,826.8

Deferred income tax liabilities, net
 
5,645.1

 
5,665.9

Other liabilities
 
1,211.9

 
745.1

Total Liabilities
 
43,864.6

 
51,510.4

 
 
 
 
 
Shareholders’ Equity:
 
 
 
 
Preferred stock, $0.01 par value, 10,000 shares authorized at June 30, 2019 and December 31, 2018; none issued
 

 

Class A common stock, $0.01 par value, 1,000,000 shares authorized at June 30, 2019 and December 31, 2018; 357,143 and 356,824 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively
 
3.6

 
3.6

Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding as of June 30, 2019 and December 31, 2018
 

 

Additional paid-in capital
 
21,109.2

 
21,054.3

Retained earnings
 
5,336.8

 
4,855.3

Accumulated other comprehensive income (loss)
 
5.6

 
5.3

Total CME Group Shareholders’ Equity
 
26,455.2

 
25,918.5

Non-controlling interests
 
29.7

 
46.8

Total Equity
 
26,484.9

 
25,965.3

Total Liabilities and Equity
 
$
70,349.5

 
$
77,475.7


See accompanying notes to unaudited consolidated financial statements.

5


CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(dollars in millions, except per share data; shares in thousands)
(unaudited)
 
 
 
Quarter Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2019
 
2018
 
2019
 
2018
Revenues
 
 
 
 
 
 
 
 
Clearing and transaction fees
 
$
1,051.8

 
$
906.1

 
$
2,004.4

 
$
1,879.7

Market data and information services
 
128.3

 
113.8

 
258.4

 
208.7

Other
 
92.6

 
39.7

 
189.5

 
80.2

Total Revenues
 
1,272.7

 
1,059.6

 
2,452.3

 
2,168.6

Expenses
 
 
 
 
 
 
 
 
Compensation and benefits
 
227.3

 
150.8

 
457.6

 
303.5

Technology
 
48.6

 
25.2

 
95.7

 
50.7

Professional fees and outside services
 
41.7

 
31.9

 
81.1

 
74.5

Amortization of purchased intangibles
 
76.1

 
23.6

 
156.8

 
47.3

Depreciation and amortization
 
46.3

 
27.5

 
79.2

 
55.6

Licensing and other fee agreements
 
44.8

 
39.9

 
85.3

 
89.4

Other
 
89.3

 
93.8

 
167.0

 
139.8

Total Expenses
 
574.1

 
392.7

 
1,122.7

 
760.8

Operating Income
 
698.6

 
666.9

 
1,329.6

 
1,407.8

 
 
 
 
 
 
 
 
 
Non-Operating Income (Expense)
 
 
 
 
 
 
 
 
Investment income
 
139.3

 
241.9

 
318.0

 
398.3

Interest and other borrowing costs
 
(45.1
)
 
(33.1
)
 
(93.2
)
 
(63.2
)
Equity in net earnings of unconsolidated subsidiaries
 
43.8

 
36.4

 
84.3

 
76.5

Other non-operating income (expense)
 
(134.5
)
 
(155.3
)
 
(296.4
)
 
(273.9
)
Total Non-Operating Income (Expense)
 
3.5

 
89.9

 
12.7

 
137.7

Income before Income Taxes
 
702.1

 
756.8

 
1,342.3

 
1,545.5

Income tax provision
 
187.5

 
190.7

 
331.8

 
380.6

Net Income
 
514.6

 
566.1

 
1,010.5

 
1,164.9

Less: net (income) loss attributable to non-controlling interests
 
(0.8
)
 

 
0.2

 

Net Income Attributable to CME Group
 
$
513.8

 
$
566.1

 
$
1,010.7

 
$
1,164.9

 
 
 
 
 
 
 
 
 
Earnings per Common Share Attributable to CME Group:
 
 
 
 
 
 
 
 
Basic
 
$
1.44

 
$
1.67

 
$
2.83

 
$
3.43

Diluted
 
1.43

 
1.66

 
2.82

 
3.42

Weighted Average Number of Common Shares:
 
 
 
 
 
 
 
 
Basic
 
357,060

 
339,465

 
356,973

 
339,386

Diluted
 
358,155

 
340,872

 
358,103

 
340,838

See accompanying notes to unaudited consolidated financial statements.

6


CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
(unaudited)
 
 
Quarter Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2019
 
2018
 
2019
 
2018
Net income
 
$
514.6

 
$
566.1

 
$
1,010.5

 
$
1,164.9

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
 
Investment securities:
 
 
 
 
 
 
 
 
Net unrealized holding gains (losses) arising during the period
 
0.9

 

 
1.7

 
(0.9
)
Reclassification of net (gains) losses on sales included in investment income
 
(0.1
)
 

 
(0.1
)
 

Income tax benefit (expense)
 
(0.2
)
 

 
(0.4
)
 
0.2

Investment securities, net
 
0.6

 

 
1.2

 
(0.7
)
Defined benefit plans:
 
 
 
 
 
 
 
 
Net change in defined benefit plans arising during the period
 

 

 
(2.7
)
 
1.7

Amortization of net actuarial (gains) losses included in compensation and benefits expense
 
1.2

 
0.6

 
2.4

 
1.3

Income tax benefit (expense)
 
(0.3
)
 
(0.2
)
 
0.1

 
(0.8
)
Defined benefit plans, net
 
0.9

 
0.4

 
(0.2
)
 
2.2

Derivative investments:
 
 
 
 
 
 
 
 
Net unrealized holding gains (losses) arising during the period
 
(0.5
)
 

 
(0.2
)
 

Amortization of effective portion of net (gains) losses on cash flow hedges included in interest expense
 
(0.3
)
 
(0.3
)
 
(0.6
)
 
(0.6
)
Income tax benefit (expense)
 
0.1

 
0.1

 
0.1

 
0.2

Derivative investments, net
 
(0.7
)
 
(0.2
)
 
(0.7
)
 
(0.4
)
Foreign currency translation:
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
1.0

 
(1.5
)
 
(3.0
)
 
(0.6
)
Income tax benefit (expense)
 
3.0

 

 
3.0

 

Foreign currency translation, net
 
4.0

 
(1.5
)
 

 
(0.6
)
Other comprehensive income (loss), net of tax
 
4.8

 
(1.3
)
 
0.3

 
0.5

Comprehensive income
 
519.4

 
564.8

 
1,010.8

 
1,165.4

Less: comprehensive (income) loss attributable to non-controlling interests
 
(0.8
)
 

 
0.2

 

Comprehensive income attributable to CME Group
 
$
518.6

 
$
564.8

 
$
1,011.0

 
$
1,165.4

See accompanying notes to unaudited consolidated financial statements.

7


CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
(dollars in millions, except per share data; shares in thousands)
(unaudited)  

 
Six Months Ended, June 30, 2019
 
Class A
Common
Stock
(Shares)
 
Class B
Common
Stock
(Shares)
 
Common
Stock and
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total CME Group Shareholders' Equity
 
Non-controlling Interest
 
Total
Shareholders’
Equity
Balance at December 31, 2018
356,824

 
3

 
$
21,057.9

 
$
4,855.3

 
$
5.3

 
$
25,918.5

 
$
46.8

 
$
25,965.3

Net income
 
 
 
 
 
 
1,010.7

 
 
 
1,010.7

 
(0.2
)
 
1,010.5

Other comprehensive income (loss)
 
 
 
 
 
 
 
 
0.3

 
0.3

 

 
0.3

Dividends on common stock of $1.50 per share
 
 
 
 
 
 
(536.1
)
 
 
 
(536.1
)
 
 
 
(536.1
)
Impact of adoption of standards updates on leasing
 
 
 
 
 
 
6.9

 
 
 
6.9

 
 
 
6.9

Changes in non-controlling interest due to measurement period adjustments
 
 
 
 
 
 
 
 
 
 

 
(16.9
)
 
(16.9
)
Exercise of stock options
162

 
 
 
7.0

 
 
 
 
 
7.0

 
 
 
7.0

Vesting of issued restricted Class A common stock
128

 
 
 
(14.1
)
 
 
 
 
 
(14.1
)
 
 
 
(14.1
)
Shares issued to Board of Directors
16

 
 
 
3.1

 
 
 
 
 
3.1

 
 
 
3.1

Shares issued under Employee Stock Purchase Plan
13

 
 
 
2.5

 
 
 
 
 
2.5

 
 
 
2.5

Stock-based compensation
 
 
 
 
56.4

 
 
 
 
 
56.4

 
 
 
56.4

Balance at June 30, 2019
357,143

 
3

 
$
21,112.8

 
$
5,336.8

 
$
5.6

 
$
26,455.2

 
$
29.7

 
$
26,484.9




















8


CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY (continued)
(dollars in millions, except per share data; shares in thousands)
(unaudited)

 
Quarter Ended, June 30, 2019
 
Class A
Common
Stock
(Shares)
 
Class B
Common
Stock
(Shares)
 
Common
Stock and
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total CME Group Shareholders' Equity
 
Non-controlling Interest
 
Total
Shareholders’
Equity
Balance at March 31, 2019
357,013

 
3

 
$
21,065.7

 
$
5,091.1

 
$
0.8

 
$
26,157.6

 
$
28.9

 
$
26,186.5

Net income
 
 
 
 
 
 
513.8

 
 
 
513.8

 
0.8

 
514.6

Other comprehensive income (loss)
 
 
 
 
 
 
 
 
4.8

 
4.8

 
 
 
4.8

Dividends on common stock of $0.75 per share
 
 
 
 
 
 
(268.1
)
 
 
 
(268.1
)
 
 
 
(268.1
)
Exercise of stock options
98

 
 
 
3.7

 
 
 
 
 
3.7

 
 
 
3.7

Vesting of issued restricted Class A common stock
3

 
 
 
(0.3
)
 
 
 
 
 
(0.3
)
 
 
 
(0.3
)
Shares issued to Board of Directors
16

 
 
 
3.1

 
 
 
 
 
3.1

 
 
 
3.1

Shares issued under Employee Stock Purchase Plan
13

 
 
 
2.5

 
 
 
 
 
2.5

 
 
 
2.5

Stock-based compensation
 
 
 
 
38.1

 
 
 
 
 
38.1

 
 
 
38.1

Balance at June 30, 2019
357,143

 
3

 
$
21,112.8

 
$
5,336.8

 
$
5.6

 
$
26,455.2

 
$
29.7

 
$
26,484.9

See accompanying notes to unaudited consolidated financial statements.

9



CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY (continued)
(dollars in millions, except per share data; shares in thousands)
(unaudited)
 
 
Six Months Ended, June 30, 2018
 
Class A
Common
Stock
(Shares)
 
Class B
Common
Stock
(Shares)
 
Common
Stock and
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Shareholders’
Equity
Balance at December 31, 2017
339,235

 
3

 
$
17,900.3

 
$
4,497.2

 
$
14.3

 
$
22,411.8

Net income
 
 
 
 
 
 
1,164.9

 
 
 
1,164.9

Other comprehensive income (loss)
 
 
 
 
 
 
 
 
0.5

 
0.5

Dividends on common stock of $1.40 per share
 
 
 
 
 
 
(476.3
)
 
 
 
(476.3
)
Impact of adoption of standards update on tax effects related to accumulated other comprehensive income and revenue recognition
 
 
 
 
 
 
(12.5
)
 
3.8

 
(8.7
)
Exercise of stock options
116

 
 
 
8.2

 
 
 
 
 
8.2

Vesting of issued restricted Class A common stock
145

 
 
 
(14.9
)
 
 
 
 
 
(14.9
)
Shares issued to Board of Directors
14

 
 
 
2.4

 
 
 
 
 
2.4

Shares issued under Employee Stock Purchase Plan
10

 
 
 
1.8

 
 
 
 
 
1.8

Stock-based compensation
 
 
 
 
33.9

 
 
 
 
 
33.9

Balance at June 30, 2018
339,520

 
3

 
$
17,931.7

 
$
5,173.3

 
$
18.6

 
$
23,123.6

 
Quarter Ended, June 30, 2018
 
Class A
Common
Stock
(Shares)
 
Class B
Common
Stock
(Shares)
 
Common
Stock and
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Shareholders’
Equity
Balance at March 31, 2018
339,435

 
3

 
$
17,907.5

 
$
4,845.4

 
$
19.9

 
$
22,772.8

Net income
 
 
 
 
 
 
566.1

 
 
 
566.1

Other comprehensive income (loss)
 
 
 
 
 
 
 
 
(1.3
)
 
(1.3
)
Dividends on common stock of $0.70 per share
 
 
 
 
 
 
(238.2
)
 
 
 
(238.2
)
Exercise of stock options
57

 
 
 
4.0

 
 
 
 
 
4.0

Vesting of issued restricted Class A common stock
4

 
 
 
(0.2
)
 
 
 
 
 
(0.2
)
Shares issued to Board of Directors
14

 
 
 
2.4

 
 
 
 
 
2.4

Shares issued under Employee Stock Purchase Plan
10

 
 
 
1.8

 
 
 
 
 
1.8

Stock-based compensation
 
 
 
 
16.2

 
 
 
 
 
16.2

Balance at June 30, 2018
339,520

 
3

 
$
17,931.7

 
$
5,173.3

 
$
18.6

 
$
23,123.6

See accompanying notes to unaudited consolidated financial statements.


10


CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)  
 
 
Six Months Ended
June 30,
 
 
2019
 
2018
Cash Flows from Operating Activities
 
 
 
 
Net income
 
$
1,010.5

 
$
1,164.9

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
Stock-based compensation
 
56.4

 
33.9

Amortization of purchased intangibles
 
156.8

 
47.3

Depreciation and amortization
 
79.2

 
55.6

Unrealized loss on assets held for sale
 
21.6

 

Unrealized loss on derivative contracts
 
16.7

 
36.9

Net realized and unrealized (gains) losses on privately-held equity investments
 
27.2

 
(88.2
)
Undistributed net earnings of unconsolidated subsidiaries
 
(31.2
)
 
(4.7
)
Deferred income taxes
 
(13.1
)
 
5.0

Change in:
 
 
 
 
Accounts receivable
 
(40.4
)
 
(75.0
)
Other current assets
 
126.1

 
36.5

Other assets
 
(13.4
)
 
(0.8
)
Accounts payable
 
(64.3
)
 
(3.5
)
Income taxes payable
 
(28.6
)
 
171.0

Other current liabilities
 
(177.7
)
 
(26.4
)
Other liabilities
 
8.5

 
(5.9
)
Other
 
8.6

 
1.2

Net Cash Provided by Operating Activities
 
1,142.9

 
1,347.8

 
 
 
 
 
Cash Flows from Investing Activities
 
 
 
 
Proceeds from maturities of available-for-sale marketable securities
 
11.6

 
3.4

Purchases of available-for-sale marketable securities
 
(8.3
)
 
(1.9
)
Purchases of property, net
 
(121.6
)
 
(29.6
)
Proceeds from sales of privately-held equity investments
 
28.4

 
20.4

Net Cash Used in Investing Activities
 
(89.9
)
 
(7.7
)
 
 
 
 
 
Cash Flows from Financing Activities
 
 
 
 
Issuance of commercial paper, net of maturities
 
239.5

 

Proceeds from debt, net of issuance costs
 

 
1,187.2

Repayment of debt
 
(569.2
)
 

Cash dividends
 
(1,159.9
)
 
(1,662.5
)
Premium payment for derivative contract
 

 
(30.0
)
Settlement of derivative contracts
 
16.0

 

Employee taxes paid on restricted stock vesting
 
(14.1
)
 
(14.9
)
Other
 
0.4

 
9.9

Net Cash Used in Financing Activities
 
(1,487.3
)
 
(510.3
)













11


CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(in millions)
(unaudited)  

 
 
Six Months Ended
June 30,
 
 
2019
 
2018
Net change in cash, cash equivalents and restricted cash
 
$
(434.3
)
 
$
829.8

Cash, cash equivalents and restricted cash, beginning of period
 
1,377.2

 
1,906.0

Cash, Cash Equivalents and Restricted Cash, End of Period
 
$
942.9

 
$
2,735.8

 
 
 
 
 
Reconciliation of cash, cash equivalents and restricted cash:
 
 
 
 
Cash and cash equivalents
 
$
937.7

 
$
1,098.9

Short-term restricted cash
 
4.1

 
1,635.5

Long-term restricted cash
 
1.1

 
1.4

Total
 
$
942.9

 
$
2,735.8

 
 

 
 
Supplemental Disclosure of Cash Flow Information
 
 
 
 
Income taxes paid
 
$
373.9

 
$
272.8

Interest paid
 
80.1

 
42.4


See accompanying notes to unaudited consolidated financial statements.

12


NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
The consolidated financial statements consist of CME Group Inc. (CME Group) and its subsidiaries (collectively, the company), including Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity Exchange, Inc. (COMEX) and NEX Group Limited (NEX). The clearing house is a division of CME.
Effective November 2, 2018, CME Group completed its acquisition of NEX. NEX offers electronic trade execution platforms for the foreign exchange and fixed income over-the-counter markets as well as other services across the transaction lifecycle, including trade and portfolio management and portfolio compression. The financial statements and accompanying notes presented in this report include the financial results of NEX and its subsidiaries beginning on November 3, 2018.
The accompanying interim consolidated financial statements have been prepared by CME Group without audit. Certain notes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. In the opinion of management, the accompanying consolidated financial statements include all normal recurring adjustments considered necessary to present fairly the financial position of the company at June 30, 2019 and December 31, 2018 and the results of operations and cash flows for the periods indicated. Quarterly results are not necessarily indicative of results for any subsequent period.
The accompanying consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in CME Group’s Annual Report on Form 10-K for the year ended December 31, 2018 , filed with the Securities and Exchange Commission (SEC) on February 28, 2019.
2. Accounting Policies
Newly Adopted Accounting Policies. In February 2016, the FASB issued a standards update that requires lessees to recognize on the balance sheet the assets and liabilities associated with the rights and obligations created by those leases. The guidance for lessors is largely unchanged from current accounting rules. Under the new guidance, a lessee will be required to recognize assets and liabilities for leases with lease terms of more than 12 months. Consistent with current accounting standards, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. The company implemented this standard as of January 1, 2019 using the modified retrospective approach with a cumulative effect of initially applying the guidance recognized on the date of initial adoption. Upon adoption of the new standard on January 1, 2019, the company recognized a lease liability of $568.0 million and right-of-use asset of $448.2 million .
Recently Issued Accounting Pronouncements. In June 2016, the FASB issued guidance that changes how credit losses are measured for most financial assets measured at amortized cost and certain other instruments. The standard requires an entity to estimate its lifetime expected credit loss and record an allowance, that when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. This forward-looking expected loss model generally will result in the earlier recognition of allowances for losses. The standard also amends the impairment model for available for sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on an available for sale debt security is a credit loss. Severity and duration of the unrealized loss are no longer permissible factors in concluding whether a credit loss exists. Entities will recognize improvements to estimated credit losses on available for sale debt securities immediately in earnings rather than as interest income over time. The standard is effective for reporting periods beginning after December 15, 2019. The standard’s provisions must be applied as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Early adoption is permitted for reporting periods beginning in 2019. The company does not believe that the adoption of this guidance in 2020 will have a material impact on the consolidated financial statements.
In August 2018, the FASB issued a standards update that modifies the disclosure requirements for employers that sponsor defined pension or other postretirement plans. The guidance clarifies certain existing disclosures and expands the requirements for others. Disclosures that are not considered cost beneficial are removed by the update. Also, there is a new disclosure requirement to include an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. This guidance is effective for reporting periods beginning in 2021. Early adoption is permitted. The company plans to update the disclosures for these changes upon adoption of the guidance in 2021.
3. Revenue Recognition
The company generates revenue from customers from the following sources:
Clearing and transaction fees. Clearing and transaction fees include electronic trading fees and brokerage commissions, surcharges for privately-negotiated transactions, portfolio reconciliation and compression services, risk mitigation and other volume-related charges for trade contracts. Clearing and transaction fees are assessed upfront at the time of trade execution. As

13


such, the company recognizes the majority of the fee revenue upon successful execution of the trade. The minimal remaining portion of the fee revenue related to settlement activities performed after trade execution is recognized over the short-term period that the contract is outstanding, based on management’s estimates of the average contract lifecycle. These estimates are based on various assumptions to approximate the amount of fee revenue to be attributed to services performed through contract settlement, expiration, or termination. For cleared trades, these assumptions include the average number of days that a contract remains in open interest, contract turnover, average revenue per day, and revenue remaining in open interest at the end of each period.
The nature of contracts gives rise to several types of variable consideration, including volume-based pricing tiers, customer incentives associated with market maker programs and other fee discounts. The company includes fee discounts and incentives in the estimated transaction price when there is a basis to reasonably estimate the amount of the fee reduction. These estimates are based on historical experience, anticipated performance, and best judgment at the time. Because of the company's certainty in estimating these amounts, they are included in the transaction price of contracts.
Market data and information services. Market data and information services represent revenue from the dissemination of market data to subscribers, distributors, and other third-party licensees of market data. Pricing for market data is primarily based on the number of reportable devices used as well as the number of subscribers enrolled under the arrangement. Fees for these services are generally billed monthly. Market data services are satisfied over time and revenue is recognized on a monthly basis as the customers receive and consume the benefit of the market data services. However, the company also maintains certain annual license arrangements with one-time upfront fees. The fees for annual licenses are initially recorded as a contract liability and recognized as revenue monthly over the term of the annual period.
Other. Other revenues include access and communication fees, fees for collateral management, fees for trade order routing through agreements from various strategic relationships, as well as other post-trade services to customers and clearing firms. Access and communication fees are charges to customers that utilize various telecommunications networks and communications services. Fees for these services are generally billed monthly and the associated fee revenue is recognized as billed. Collateral management fees are charged to clearing firms that have collateral on deposit with CME to meet their minimum performance bond and guaranty fund obligations on the exchange. These fees are calculated based on daily collateral balances and are billed monthly. This fee revenue is recognized monthly as billed as the customers receive and consume the benefits of the services. Pricing for strategic relationships may be driven by customer levels and activity. There are fee arrangements which provide for monthly as well as quarterly payments in arrears. Revenue is recognized monthly for strategic relationship arrangements as the customers receive and consume the benefits of the services.
The following table represents a disaggregation of revenue from contracts with customers for the quarters and six months ended June 30, 2019 and 2018:
 
 
Quarter Ended
June 30,
 
Six Months Ended
June 30,
(in millions)
 
2019
 
2018
 
2019
 
2018
Interest rates
 
$
347.4

 
$
288.9

 
$
650.2

 
$
627.3

Equity indexes
 
148.1

 
157.3

 
294.0

 
352.3

Foreign exchange
 
39.3

 
49.1

 
80.5

 
100.2

Agricultural commodities
 
141.5

 
141.4

 
246.5

 
262.5

Energy
 
179.3

 
192.0

 
344.3

 
383.6

Metals
 
58.1

 
60.5

 
109.1

 
119.9

Cash markets business
 
120.7

 

 
243.6

 

Interest rate swap
 
17.4

 
16.9

 
36.2

 
33.9

Total clearing and transaction fees
 
1,051.8

 
906.1

 
2,004.4

 
1,879.7

Market data and information services
 
128.3

 
113.8

 
258.4

 
208.7

Other
 
92.6

 
39.7

 
189.5

 
80.2

Total revenues
 
$
1,272.7

 
$
1,059.6

 
$
2,452.3

 
$
2,168.6

 
 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
 
Services transferred at a point in time
 
988.1

 
890.6

 
$
1,881.0

 
$
1,848.4

Services transferred over time
 
281.9

 
166.7

 
559.6

 
315.5

One-time charges and miscellaneous revenues
 
2.7

 
2.3

 
11.7

 
4.7

Total revenues
 
$
1,272.7

 
$
1,059.6

 
$
2,452.3

 
$
2,168.6



14


The timing of revenue recognition, billings and cash collections results in billed accounts receivable, and customer advances and deposits (contract liabilities) on the consolidated balance sheets. Certain fees for transactions, annual licenses, and other revenue arrangements are billed upfront before revenue is recognized, which results in the recognition of contract liabilities. These liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. For annual licenses and upfront fee arrangements, the company generally bills customers upon contract execution. These payments are recognized as revenue over time as the obligations under the contracts are satisfied. Changes in the contract liability balances during the six months ended June 30, 2019 were not materially impacted by any other factors. The balance of contract liabilities was $57.9 million and $44.4 million as of June 30, 2019 and December 31, 2018 , respectively.    
4. Performance Bonds and Guaranty Fund Contributions
Performance Bonds and Guaranty Fund Contributions. CME has been designated as a systemically important financial market utility by the Financial Stability Oversight Council and is authorized to establish and maintain a cash account at the Federal Reserve Bank of Chicago. At June 30, 2019 , CME maintained $16.7 billion within the cash account at the Federal Reserve Bank of Chicago. The cash deposit at the Federal Reserve Bank of Chicago is included within performance bonds and guaranty fund contributions on the consolidated balance sheets.
Clearing House Contract Settlement. The clearing house marks-to-market open positions for all futures and options contracts twice a day (once a day for CME's cleared-only interest rate swap contracts). Based on values derived from the mark-to-market process, the clearing house requires payments from clearing firms whose positions have lost value and makes payments to clearing firms whose positions have gained value. Under the extremely unlikely scenario of simultaneous default by every clearing firm who has open positions with unrealized losses, the maximum exposure related to positions other than cleared-only interest rate swap contracts would be one half day of changes in fair value of all open positions, before considering the clearing house's ability to access defaulting clearing firms' collateral deposits.
For CME's cleared-only interest rate swap contracts, the maximum exposure related to CME's guarantee would be one full day of changes in fair value of all open positions, before considering CME's ability to access defaulting clearing firms' collateral.
During the first six months of 2019, the clearing house transferred an average of approximately $3.1 billion a day through its clearing systems for settlement from clearing firms whose positions had lost value to clearing firms whose positions had gained value. The clearing house reduces its guarantee exposure through initial and maintenance performance bond requirements and mandatory guaranty fund contributions. The company believes that its guarantee liability is immaterial and therefore has not recorded any liability at June 30, 2019 .
5. Intangible Assets
Intangible assets consisted of the following at June 30, 2019 and December 31, 2018 :
 
 
 
June 30, 2019
 
December 31, 2018
(in millions)
 
Assigned Value
 
Accumulated
Amortization
 
Net Book
Value
 
Assigned Value
 
Accumulated
Amortization
 
Net Book
Value
Amortizable Intangible Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Clearing firm, market data and other customer relationships
 
$
5,828.1

 
$
(1,206.2
)
 
$
4,621.9

 
$
5,862.5

 
$
(1,065.6
)
 
$
4,796.9

Technology-related intellectual property
 
178.7

 
(36.2
)
 
142.5

 
179.1

 
(25.6
)
 
153.5

Other
 
103.3

 
(9.0
)
 
94.3

 
102.8

 
(3.1
)
 
99.7

Total amortizable intangible assets
 
$
6,110.1

 
$
(1,251.4
)
 
4,858.7

 
$
6,144.4

 
$
(1,094.3
)
 
5,050.1

 
 
 
 
 
 
 
 
 
 
 
 
 
Indefinite-Lived Intangible Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Trade names
 
 
 
 
 
450.0

 
 
 
 
 
450.0

Total intangible assets – other, net
 
 
 
 
 
$
5,308.7

 
 
 
 
 
$
5,500.1

Trading products (1)
 
 
 
 
 
$
17,175.3

 
 
 
 
 
$
17,175.3


(1)
Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits.
Total amortization expense for intangible assets was $76.1 million and $23.6 million for the quarters ended June 30, 2019 and

15


2018 , respectively. Total amortization expense for intangible assets was $156.8 million and $47.3 million for the six months ended June 30, 2019 and 2018 , respectively.
As of June 30, 2019 , the future estimated amortization expense related to amortizable intangible assets is expected to be as follows:
(in millions)
 Amortization Expense
Remainder of 2019
$
157.8

2020
315.5

2021
315.4

2022
315.0

2023
313.6

2024
307.0

Thereafter
3,134.4


Goodwill activity consisted of the following at June 30, 2019 and December 31, 2018 :
(in millions)
 
Balance at December 31, 2018
 
Business
Combinations
 
Other
Activity (1)
 
Balance at June 30, 2019
CBOT Holdings
 
$
5,066.4

 
$

 
$

 
$
5,066.4

NYMEX Holdings
 
2,462.2

 

 

 
2,462.2

NEX
 
3,236.3

 

 
(10.0
)
 
3,226.3

Other
 
40.4

 

 

 
40.4

Total Goodwill
 
$
10,805.3

 
$

 
$
(10.0
)
 
$
10,795.3

(in millions)
 
Balance at December 31, 2017
 
Business
Combinations
 
Other
Activity
 
Balance at December 31, 2018
CBOT Holdings
 
$
5,066.4

 
$

 
$

 
$
5,066.4

NYMEX Holdings
 
2,462.2

 

 

 
2,462.2

NEX
 

 
3,236.3

 

 
3,236.3

Other
 
40.4

 

 

 
40.4

Total Goodwill
 
$
7,569.0

 
$
3,236.3

 
$

 
$
10,805.3


(1) Other activity includes measurement period adjustments, including adjustments to intangible assets, fixed assets, other assets and accrued liabilities, as well as goodwill associated with assets held for sale. The company expects to finalize its purchase price allocation of net tangible and intangible assets within the first year following the acquisition date of NEX.
6. Debt
In March 2019, the company repaid both the €350.0 million fixed rates notes and the ¥19.1 billion term loan.
Short-term debt outstanding consisted of the following at June 30, 2019 and December 31, 2018 (in U.S. dollar equivalent):
(in millions)
 
June 30, 2019
 
December 31, 2018
€350.0 million fixed rate notes due March 2019, stated rate of 3.13%
 
$

 
$
400.7

¥19.1 billion term loan due March 2019, stated rate of 0.81%
 

 
173.5

Total short-term debt
 
$

 
$
574.2



16


Long-term debt consisted of the following at June 30, 2019 and December 31, 2018 :  
(in millions)
 
June 30, 2019
 
December 31, 2018
$750.0 million fixed rate notes due September 2022, stated rate of 3.00%  (1)
 
$
747.3

 
$
746.9

€15.0 million fixed rate notes due May 2023, stated rate of 4.30%
 
16.6

 
16.6

$750.0 million fixed rate notes due March 2025, stated rate of 3.00% (2)
 
745.9

 
745.6

$500.0 million fixed rate notes due June 2028, stated rate of 3.75%
 
496.1

 
495.9

$750.0 million fixed rate notes due September 2043, stated rate of 5.30% (3)
 
742.6

 
742.4

$700.0 million fixed rate notes due June 2048, stated rate of 4.15%
 
689.7

 
689.5

Commercial paper (4)
 
634.7

 
389.9

Total long-term debt
 
$
4,072.9

 
$
3,826.8

(1)
The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.32% .
(2)
The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.11% .
(3)
The company maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 4.73% .
(4)
The commercial paper is backed by the five-year multi-currency revolving credit facility.
Commercial paper with an aggregate par value of $6.9 billion and maturities ranging from 1 to 18 days was issued during the first six months of 2019. The weighted average discount rate of commercial paper outstanding at June 30, 2019 was 2.40% . The weighted average balance of commercial paper outstanding during the first six months of 2019 was $468.8 million .
Long-term debt maturities, at par value (in U.S. dollar equivalent), were as follows at June 30, 2019 :  
(in millions)
Par Value
2020
$

2021

2022
1,385.0

2023
17.1

2024

Thereafter
2,700.0


Commercial paper is considered to mature in 2022 because it is backed by the five-year multi-currency revolving credit facility, which expires in 2022.
7. Contingencies
Legal and Regulatory Matters. In 2013, the CFTC filed suit against NYMEX and two former employees alleging disclosure of confidential customer information in violation of the Commodity Exchange Act. NYMEX’s motion to dismiss was denied in 2014. Based on its investigation to date and advice from legal counsel, the company believes that it has strong factual and legal defenses to the claim.
In 2003, the U.S. Futures Exchange, L.L.C. (Eurex U.S.) and U.S. Exchange Holdings, Inc. filed suit in federal court alleging that CBOT and CME violated the antitrust laws and tortuously interfered with the business relationship and contract between Eurex U.S. and The Clearing Corporation. On October 31, 2018, the Court granted CBOT's and CME's motion for summary judgment and dismissed the case in its entirety. Eurex has appealed this decision.
In the normal course of business, the company discusses matters with its regulators raised during regulatory examinations or otherwise subject to their inquiry and oversight. These matters could result in censures, fines, penalties or other sanctions. Management believes the outcome of any resulting actions will not have a material impact on its consolidated financial position or results of operations. However, the company is unable to predict the outcome or the timing of the ultimate resolution of these matters, or the potential fines, penalties or injunctive or other equitable relief, if any, that may result from these matters.
In addition, the company is a defendant in, and has potential for, various other legal proceedings arising from its regular business activities. While the ultimate results of such proceedings against the company cannot be predicted with certainty, the

17


company believes that the resolution of any of these matters on an individual or aggregate basis will not have a material impact on its consolidated financial position or results of operations.
No accrual was required for legal and regulatory matters as none were probable and estimable as of June 30, 2019 and December 31, 2018 .
Intellectual Property Indemnifications . Certain agreements with customers and other third parties related to accessing CME Group’s services may contain indemnifications from intellectual property claims that may be made against them as a result of their use of the applicable services. The potential future claims relating to these indemnifications cannot be estimated and therefore no liability has been recorded.
8. Leases
The company adopted the new leasing standard on January 1, 2019, using the modified retrospective approach. The standard requires lessees to recognize on the balance sheet the assets and liabilities associated with the rights and obligations created by those leases. Upon implementation of the standard, the company utilized the package of practical expedients which did not require reassessment of the following: (a) whether any expired or existing contracts are or contain leases, (b) the lease classification for any expired or existing leases, and (c) any initial direct costs for existing leases. In addition, the company has elected not to separately account for lease and non-lease components, resulting in a greater amount of capitalized lease costs on the balance sheet. Upon adoption of the new standard on January 1, 2019, the company recognized a lease liability of $568.0 million and right-of-use asset of $448.2 million .
The company has operating leases for datacenters, corporate offices, and certain information technology equipment. The operating leases have remaining lease terms of up to 19 years, some of which include options to extend or renew the leases for up to an additional 5 years, and some of which include options to early terminate the leases in less than 12 months. Management evaluates the exercisability of these options at least quarterly in order to determine whether the contract term must be reassessed. For a small number of the leases, primarily the international locations, management's approach is to enter into short-term leases for a lease term of 12 months or less in order to provide for greater flexibility in the local environment. For certain office spaces, the company has entered into arrangements to sublease excess space to third parties, while the original lease contract remains in effect with the landlord.
The company also has three finance leases, one of which is related to the sale of our datacenter in March 2016. In connection with the sale, the company leased back a portion of the property. The sale leaseback transaction was recognized under the financing method and not as a sale leaseback arrangement. We have two other finance leases related to networking equipment and connectivity hardware. These leases qualify for classification as finance leases due to our exercise of an existing purchase option on this equipment.
The right-of-use lease asset is recorded within other assets, and the present value of the lease liability is recorded within other liabilities (segregated between short term and long term) on the consolidated balance sheets. The discount rate applied to the lease payments represents the company's incremental borrowing rate. The company has elected to utilize the short term lease exception for purposes of adopting this standard, such that the company has not capitalized on the balance sheet a lease asset or lease liability associated with leases with terms of 12 months or less from the commencement date.
The components of lease costs were as follows:
(in millions)
Quarter Ended
June 30, 2019
 
Six Months Ended
June 30, 2019
Operating lease expense:
 
 
 
Operating lease cost
$
18.9

 
$
37.3

Short-term lease cost
1.5

 
4.9

Total operating lease expense included in other expense
$
20.4

 
$
42.2

 
 
 
 
Finance lease expense:
 
 
 
Interest expense
$
0.9

 
$
1.8

Depreciation expense
2.4

 
4.6

Total finance lease expense
$
3.3

 
$
6.4

 
 
 
 
Sublease revenue included in other revenue
$
1.7

 
$
5.3



18


Supplemental cash flow information related to leases was as follows:
(in millions)
Quarter Ended
June 30, 2019
 
Six Months Ended
June 30, 2019
Cash outflows for operating leases
$
16.9

 
$
32.1

Cash outflows for finance leases
4.8

 
9.0


Supplemental balance sheet information related to leases was as follows:
Operating leases
(in millions)
June 30, 2019
Operating lease right-of-use assets
$
433.5

 
 
Operating lease liabilities:
 
Other current liabilities
$
41.3

Other liabilities
524.3

Total operating lease liabilities
$
565.6

 
 
Weighted average remaining lease term (in months)
151

Weighted average discount rate
4.0
%

Finance leases
(in millions)
June 30, 2019
Finance lease right-of-use assets
$
102.9

 
 
Finance lease liabilities:
 
Other current liabilities
$
8.9

Other liabilities
95.2

Total finance lease liabilities
$
104.1

 
 
Weighted average remaining lease term (in months)
140

Weighted average discount rate
3.5
%

Future minimum lease payments were as follows as of June 30, 2019 for operating and finance leases:
(in millions)
Operating Leases
Remainder of 2019
$
31.5

2020
63.3

2021
60.1

2022
62.9

2023
59.0

2024
53.4

Thereafter
399.0

Total lease payments
729.2

Less: imputed interest
(163.6
)
Present value of lease liability
$
565.6




19


(in millions)
Finance Leases
Remainder of 2019
$
9.9

2020
16.9

2021
17.0

2022
17.1

2023
17.2

2024
17.4

Thereafter
111.8

Total lease payments
207.3

Less: imputed interest
(103.2
)
Present value of lease liability
$
104.1


9. Guarantees
Mutual Offset Agreement. CME and Singapore Exchange Limited (SGX) have a mutual offset agreement with a current term through October 2019. This agreement enables market participants to open a futures position on one exchange and liquidate it on the other. The term of the agreement will automatically renew for a one -year period unless either party provides advance notice of their intent to terminate. CME can maintain collateral in the form of U.S. Treasury securities or irrevocable, standby letters of credit. At June 30, 2019 , CME was contingently liable to SGX on letters of credit totaling $335.0 million . Regardless of the collateral, CME guarantees all cleared transactions submitted through SGX and would initiate procedures designed to satisfy these financial obligations in the event of a default, such as the use of performance bonds and guaranty fund contributions of the defaulting clearing firm. The company believes that its guarantee liability is immaterial and therefore has not recorded any liability at June 30, 2019 .
Family Farmer and Rancher Protection Fund. In 2012, the company established the Family Farmer and Rancher Protection Fund (the Fund). The Fund is designed to provide payments, up to certain maximum levels, to family farmers, ranchers and other agricultural industry participants who use the company's agricultural commodity products and who suffer losses to their segregated account balances due to their CME clearing member becoming insolvent. Under the terms of the Fund, farmers and ranchers are eligible for up to $25,000 per participant. Farming and ranching cooperatives are eligible for up to $100,000 per cooperative. The Fund was established with a maximum of $100.0 million available for distribution to participants. Since its establishment, the Fund has made payments of approximately $2.0 million , which leaves $98.0 million available for future claims. If, at any time, payments due to participants were to exceed the amount remaining in the fund, payments would be pro-rated. Clearing members and customers must register with the company in advance and provide certain documentation in order to substantiate their eligibility. The company believes that its guarantee liability is immaterial and therefore has not recorded any liability at June 30, 2019 .

20


10. Accumulated Other Comprehensive Income (Loss)
The following tables present changes in the accumulated balances for each component of other comprehensive income (loss), including current period other comprehensive income (loss) and reclassifications out of accumulated other comprehensive income (loss):